International Council for Harmonisation Guideline E2D

Target entity: International Council for Harmonisation Guideline E2D
Context triple: [ICH E2D, abbreviationOf, International Council for Harmonisation Guideline E2D]

• A. International Council for Harmonisation guideline E2C
  International Council for Harmonisation guideline E2C is a regulatory framework that provides standardized requirements for the ongoing safety evaluation and periodic benefit-risk assessment of marketed medicinal products.
• B. ICH E8 General Considerations for Clinical Trials
  ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
• C. ICH E9 Statistical Principles for Clinical Trials
  ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.
• D. ICH E2A Clinical Safety Data Management
  ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
• E. ICH E6 Good Clinical Practice
  ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: International Council for Harmonisation Guideline E2D
Target entity description: International Council for Harmonisation Guideline E2D is a regulatory guideline that provides standards for the management and reporting of post-approval safety data for medicinal products in order to enhance pharmacovigilance and patient safety globally.

• A. International Council for Harmonisation guideline E2C
  International Council for Harmonisation guideline E2C is a regulatory framework that provides standardized requirements for the ongoing safety evaluation and periodic benefit-risk assessment of marketed medicinal products.
• B. ICH E8 General Considerations for Clinical Trials
  ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
• C. ICH E9 Statistical Principles for Clinical Trials
  ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.
• D. ICH E2A Clinical Safety Data Management
  ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
• E. ICH E6 Good Clinical Practice
  ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
• F. None of above. chosen